Dallas TX 血液癌症临床试验
12项针对 血液癌症的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
招募中3 期
- Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
招募中2 期
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
招募中1/2 期
- Baylor Scott & White Health, Dallas
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- Texas Oncology-Presbyterian Cancer Center, Dallas
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
招募中1 期
- UT Southwestern Medical Center, Dallas
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
招募中3 期
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
招募中
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- UT Southwestern - Simmons Cancer Center, Dallas
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- University of Texas, Southwestern, Dallas
其他城市的 血液癌症试验
- Houston, TX46 项研究
- New York City, NY26 项研究
- Boston, MA25 项研究
- Washington, DC19 项研究
- Baltimore, MD18 项研究
- Seattle, WA18 项研究
- Los Angeles, CA17 项研究
- Durham, NC16 项研究
- Chicago, IL15 项研究
- Philadelphia, PA14 项研究
- Atlanta, GA13 项研究
- Nashville, TN13 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 癌症（所有类型）37 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 膀胱癌27 项研究
- 肺癌27 项研究
- 子宫内膜癌24 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。